Company Filing History:
2 out of 451 
1 out of 832,891 Years Active: 1989-1993
Title: Discovering the Innovations of Steven D. Gimpel
Introduction
Steven D. Gimpel, an accomplished inventor based in Seattle, WA, has made significant contributions to the field of biotechnology. With a total of three patents to his name, Gimpel's innovations focus on enhancing the production of specific proteins that have applications in the medical and pharmaceutical industries.
Latest Patents
One of Gimpel's latest patents is titled "Analogs of Human Granulocyte-Macrophage Colony Stimulating Factor." This invention involves the amplified expression of recombinant DNA products achieved in hosts that express proteases which cleave at multi-basic amino acid residues. To improve the efficacy of the expressed proteins, Gimpel's work includes mutating wild-type genes by substituting or eliminating codons for multi-basic amino acid residues while ensuring the activity of the expressed protein is maintained. This mutation process can be conveniently executed through site-specific in vitro mutagenesis.
Another noteworthy patent is the "Process for Preparing Bovine Interleukin-2." In this innovation, Gimpel outlines a method for preparing bovine interleukin-2 (bIL-2) by culturing a microbial host transformed by a vector containing a DNA sequence encoding bIL-2. This process is designed so that the bIL-2 is expressed and can be effectively recovered for further use.
Career Highlights
Steven D. Gimpel has had a notable career in the field of biotechnology, working for reputable companies such as Immunex Corporation. His expertise in genetic engineering and protein expression has led him to develop groundbreaking patents that enhance the production of critical therapeutic proteins.
Collaborations
Throughout his career, Gimpel has collaborated with esteemed colleagues such as Dirk M. Anderson and Paul E. Baker. These collaborations have played a vital role in advancing his research and developing his innovative solutions within the industry.
Conclusion
Steven D. Gimpel exemplifies the spirit of innovation in biotechnology. With his patents aimed at revolutionizing the production of important proteins, his work has the potential to make notable impacts in medical treatments and beyond. Gimpel continues to inspire future inventors in the scientific community through his dedication and contributions to the field.